Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism (STEADY)

Evaluation of efficacy and safety of testosterone enanthate administered subcutaneously using an auto-injector


Study Type: Interventional
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double-blind, Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Enrollment: 150
Study Start Date: July 2014
Study Completion Date: November 2015
Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)

Arms:
- Experimental: Testosterone enanthate auto-injector